
Results
3
3 companies
Kuros Biosciences
Market Cap: CHF 914.8m
Engages in the commercialization and development of biologic technologies for musculoskeletal care in the United States of America, the European Union, and internationally.
KURN
CHF 23.06
7D
1.8%
1Y
-14.0%
MindMaze Therapeutics Holding
Market Cap: CHF 36.8m
Operates as a commercial-stage biopharmaceutical and neurotechnology company in Asia, the United States, Switzerland, rest of Europe, and internationally.
MMTX
CHF 0.24
7D
21.0%
1Y
n/a
Cosmo
Market Cap: CHF 1.1b
A life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally.
COPN
CHF 61.70
7D
2.8%
1Y
10.2%